148 related articles for article (PubMed ID: 19928862)
41. Synthesis and biological evaluation of 14-alkoxymorphinans. 17. Highly delta opioid receptor selective 14-alkoxy-substituted indolo- and benzofuromorphinans.
Schütz J; Dersch CM; Horel R; Spetea M; Koch M; Meditz R; Greiner E; Rothman RB; Schmidhammer H
J Med Chem; 2002 Nov; 45(24):5378-83. PubMed ID: 12431065
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and opiate receptor binding properties of 17-methyl-6,7-dehydro-3,14-dihydroxy-4,5alpha-epoxy-6,7:4',5'-pyrimidin omorphinans.
Xu W; Huang LF; Bauer L; Bhargava HN; Dunn WJ
Bioorg Med Chem Lett; 1999 Dec; 9(23):3375-80. PubMed ID: 10612602
[TBL] [Abstract][Full Text] [Related]
43. Synthesis of quinolinomorphinan derivatives as highly selective δ opioid receptor ligands.
Ida Y; Matsubara A; Nemoto T; Saito M; Hirayama S; Fujii H; Nagase H
Bioorg Med Chem; 2012 Oct; 20(19):5810-31. PubMed ID: 22967810
[TBL] [Abstract][Full Text] [Related]
44. Novel 6β-acylaminomorphinans with analgesic activity.
Váradi A; Hosztafi S; Le Rouzic V; Tóth G; Urai Á; Noszál B; Pasternak GW; Grinnell SG; Majumdar S
Eur J Med Chem; 2013 Nov; 69():786-9. PubMed ID: 24103580
[TBL] [Abstract][Full Text] [Related]
45. Probes for narcotic receptor mediated phenomena. 48. C7- and C8-substituted 5-phenylmorphan opioids from diastereoselective alkylation.
Lim HJ; Dersch CM; Rothman RB; Deschamps JR; Jacobson AE; Rice KC
Eur J Med Chem; 2013 Sep; 67():335-43. PubMed ID: 23880358
[TBL] [Abstract][Full Text] [Related]
46. N-Substituted 9beta-methyl-5-(3-hydroxyphenyl)morphans are opioid receptor pure antagonists.
Thomas JB; Zheng X; Mascarella SW; Rothman RB; Dersch CM; Partilla JS; Flippen-Anderson JL; George CF; Cantrell BE; Zimmerman DM; Carroll FI
J Med Chem; 1998 Oct; 41(21):4143-9. PubMed ID: 9767649
[TBL] [Abstract][Full Text] [Related]
47. The effect of 17-N substituents on the activity of the opioid κ receptor in nalfurafine derivatives.
Nemoto T; Yamamoto N; Wada N; Harada Y; Tomatsu M; Ishihara M; Hirayama S; Iwai T; Fujii H; Nagase H
Bioorg Med Chem Lett; 2013 Jan; 23(1):268-72. PubMed ID: 23200250
[TBL] [Abstract][Full Text] [Related]
48. Synthesis of 7-arylmorphinans. Probing the "address" requirements for selectivity at opioid delta receptors.
Gao P; Larson DL; Portoghese PS
J Med Chem; 1998 Jul; 41(16):3091-8. PubMed ID: 9685249
[TBL] [Abstract][Full Text] [Related]
49. 4'-Arylpyrrolomorphinans: effect of a pyrrolo-N-benzyl substituent in enhancing delta-opioid antagonist activity.
Srivastava SK; Husbands SM; Aceto MD; Miller CN; Traynor JR; Lewis JW
J Med Chem; 2002 Jan; 45(2):537-40. PubMed ID: 11784158
[TBL] [Abstract][Full Text] [Related]
50. Syntheses of 4,6'-epoxymorphinan derivatives and their pharmacologies.
Nemoto T; Fujii H; Narita M; Miyoshi K; Nakamura A; Suzuki T; Nagase H
Bioorg Med Chem; 2008 Apr; 16(8):4304-12. PubMed ID: 18337104
[TBL] [Abstract][Full Text] [Related]
51. Modulation of opioid receptor affinity and efficacy via N-substitution of 9β-hydroxy-5-(3-hydroxyphenyl)morphan: Synthesis and computer simulation study.
Truong PM; Hassan SA; Lee YS; Kopajtic TA; Katz JL; Chadderdon AM; Traynor JR; Deschamps JR; Jacobson AE; Rice KC
Bioorg Med Chem; 2017 Apr; 25(8):2406-2422. PubMed ID: 28314512
[TBL] [Abstract][Full Text] [Related]
52. Highly selective kappa-opioid analgesics. 2. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide derivatives.
Halfpenny PR; Hill RG; Horwell DC; Hughes J; Hunter JC; Johnson S; Rees DC
J Med Chem; 1989 Jul; 32(7):1620-6. PubMed ID: 2567782
[TBL] [Abstract][Full Text] [Related]
53. The most effective influence of 17-(3-ethoxypropyl) substituent on the binding affinity and the agonistic activity in KNT-127 derivatives, δ opioid receptor agonists.
Nemoto T; Ida Y; Iihara Y; Nakajima R; Hirayama S; Iwai T; Fujii H; Nagase H
Bioorg Med Chem; 2013 Dec; 21(24):7628-47. PubMed ID: 24262888
[TBL] [Abstract][Full Text] [Related]
54. In vivo characterization of (-)(-)MCL-144 and (+)(-)MCL-193: isomeric, bivalent ligands with mu/kappa agonist properties.
Mathews JL; Fulton BS; Negus SS; Neumeyer JL; Bidlack JM
Neurochem Res; 2008 Oct; 33(10):2142-50. PubMed ID: 18528756
[TBL] [Abstract][Full Text] [Related]
55. The Pharmacological Heterogeneity of Nepenthone Analogs in Conferring Highly Selective and Potent κ-Opioid Agonistic Activities.
Li W; Long JD; Qian YY; Long Y; Xu XJ; Wang YJ; Shen Q; Wang ZN; Yang XC; Xiao L; Sun HP; Xu YL; Chen YY; Xie Q; Wang YH; Shao LM; Liu JG; Qiu ZB; Fu W
ACS Chem Neurosci; 2017 Apr; 8(4):766-776. PubMed ID: 28033462
[TBL] [Abstract][Full Text] [Related]
56. Probes for narcotic receptor-mediated phenomena. 20. Alteration of opioid receptor subtype selectivity of the 5-(3-hydroxyphenyl)morphans by application of the message-address concept: preparation of delta-opioid receptor ligands.
Bertha CM; Flippen-Anderson JL; Rothman RB; Porreca F; Davis P; Xu H; Becketts K; Cha XY; Rice KC
J Med Chem; 1995 Apr; 38(9):1523-37. PubMed ID: 7739011
[TBL] [Abstract][Full Text] [Related]
57. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.
Schiller PW; Berezowska I; Nguyen TM; Schmidt R; Lemieux C; Chung NN; Falcone-Hindley ML; Yao W; Liu J; Iwama S; Smith AB; Hirschmann R
J Med Chem; 2000 Feb; 43(4):551-9. PubMed ID: 10691681
[TBL] [Abstract][Full Text] [Related]
58. Chemistry of opium alkaloids. Part 44: synthesis and opioid receptor binding profile of substituted ethenoisomorphinans and ethenomorphinans.
Maat L; Woudenberg RH; Meuzelaar GJ; Linders JT
Bioorg Med Chem; 1999 Mar; 7(3):529-41. PubMed ID: 10220038
[TBL] [Abstract][Full Text] [Related]
59. Phenylmorphans and analogues: opioid receptor subtype selectivity and effect of conformation on activity.
Froimowitz M; Pick CG; Pasternak GW
J Med Chem; 1992 May; 35(9):1521-5. PubMed ID: 1315868
[TBL] [Abstract][Full Text] [Related]
60. Agonist and antagonist opioid activity of axial and equatorial conformations of S-methyl- and S-allyl-morphinans.
Lemaire S; Belleau B; Jolicoeur FB
Eur J Pharmacol; 1994 Jun; 258(1-2):111-8. PubMed ID: 7925589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
